Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News scPharmaceuticals Inc SCPH

Healthcare
scPharmaceuticals Inc. is a pharmaceutical company. The Company is focused on developing and commercializing products to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The Company develops, internally and through strategic partnerships, products and solutions that aim to expand and advance the outpatient care of select acute conditions. Its lead... see more

Recent & Breaking News (NDAQ:SCPH)

scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024

GlobeNewswire 2 days ago

scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024

GlobeNewswire October 15, 2024

scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire September 4, 2024

scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire August 14, 2024

scPharmaceuticals Announces Pricing of $50.0 Million Public Offering

GlobeNewswire August 12, 2024

scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive Advisors

GlobeNewswire August 12, 2024

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX Indication in Heart Failure

GlobeNewswire August 12, 2024

scPharmaceuticals Announces Positive Topline Study Results for SCP-111 (Furosemide 80 mg/1 mL) Autoinjector

GlobeNewswire August 12, 2024

scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire August 12, 2024

scPharmaceuticals to Announce Second Quarter 2024 Financial Results on Wednesday, August 14, 2024

GlobeNewswire August 8, 2024

scPharmaceuticals Announces Filing Acceptance of Supplemental New Drug Application (sNDA) Seeking to Expand FUROSCIX Indication to Include Chronic Kidney Disease

GlobeNewswire July 25, 2024

scPharmaceuticals to Present at the Jefferies Global Healthcare Conference

GlobeNewswire May 29, 2024

scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire May 14, 2024

scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

GlobeNewswire May 13, 2024

scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024

GlobeNewswire May 7, 2024

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

GlobeNewswire April 24, 2024

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

GlobeNewswire March 13, 2024

scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024

GlobeNewswire March 6, 2024

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

GlobeNewswire February 28, 2024

scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue

GlobeNewswire January 4, 2024